Manuel Grez
Frankfurt Am Main, HE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
Retroviral gene therapy in Germany with a view on previous experience and future perspectives.
Journal: Gene therapy
Published: October 02, 2020
Lentiviral gene therapy for X-linked chronic granulomatous disease.
Journal: Nature medicine
Published: July 18, 2019
Non-Clinical Efficacy and Safety Studies on G1XCGD, a Lentiviral Vector for Ex Vivo Gene Therapy of X-Linked Chronic Granulomatous Disease.
Journal: Human gene therapy. Clinical development
Published: April 18, 2018
Compatibility of RUNX1/ETO fusion protein modules driving CD34+ human progenitor cell expansion.
Journal: Oncogene
Published: December 16, 2017
Suppression of RUNX1/ETO oncogenic activity by a small molecule inhibitor of tetramerization.
Journal: Haematologica
Published: February 04, 2017
A small, portable RNA device for the control of exon skipping in mammalian cells.
Journal: Nucleic acids research
Published: September 11, 2016
UPF1 regulates myeloid cell functions and S100A9 expression by the hnRNP E2/miRNA-328 balance.
Journal: Scientific reports
Published: May 12, 2016
MiR144/451 Expression Is Repressed by RUNX1 During Megakaryopoiesis and Disturbed by RUNX1/ETO.
Journal: PLoS genetics
Published: October 29, 2015
Rapamycin and WYE-354 suppress human gallbladder cancer xenografts in mice.
Journal: Oncotarget
Published: May 12, 2015
Last Updated: 09/26/2026